OMB APPROVAL |
||
OMB Number: 3235-0145 |
||
Expires: February 28, 2009 |
||
Estimated average burden hours per response...10.4 |
||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. _____)*
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o Rule 13d-1(b)
o Rule 13d-1(c)
þ Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Page 1 of 13
CUSIP No. |
00826A 1G 9 |
1 | NAMES OF REPORTING PERSONS: | ||||
I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS (ENTITIES ONLY): MPM BioVentures II, L.P. |
|||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Delaware | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 109,213 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 109,213 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
109,213 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
0.76% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
PN |
Page 2 of 13
CUSIP No. |
00826A 1G 9 |
1 | NAMES OF REPORTING PERSONS: | ||||
I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS (ENTITIES ONLY): MPM BioVentures II-QP, L.P. |
|||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Delaware | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 989,697 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 989,697 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
989,697 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
6.92% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
PN |
Page 3 of 13
CUSIP No. |
00826A 1G 9 |
1 | NAMES OF REPORTING PERSONS: | ||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
|||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Germany | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 348,491 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 348,491 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
348,491 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
2.43% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
PN |
Page 4 of 13
CUSIP No. |
00826A 1G 9 |
1 | NAMES OF REPORTING PERSONS: | ||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): MPM Asset Management Investors 2001 LLC |
|||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Delaware | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 20,548 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 20,548 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
20,548 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
0.14% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
OO |
Page 5 of 13
CUSIP No. |
00826A 1G 9 |
1 | NAMES OF REPORTING PERSONS: | ||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): MPM BioVentures Strategic Fund, L.P. |
|||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Delaware | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 132,520 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 132,520 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
132,520 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
0.93% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
PN |
Page 6 of 13
CUSIP No. |
00826A 1G 9 |
1 | NAMES OF REPORTING PERSONS: | ||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): Ansbert Gadicke |
|||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
United States | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 1,600,469* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | |||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
1,600,469* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
1,600,469* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
11.18% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
IN |
Page 7 of 13
CUSIP No. |
00826A 1G 9 |
1 | NAMES OF REPORTING PERSONS: | ||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): Luke Evnin |
|||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
United States | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 1,600,469* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
1,600,469* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
1,600,469* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
11.18% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
IN |
Page 8 of 13
(a) | Name of Issuer | ||
Affymax, Inc. | |||
(b) | Address of Issuers Principal Executive Offices | ||
4001 Miranda Avenue Palo Alto, CA 94304 |
(a) | Name of Person Filing |
MPM BioVentures II, LP MPM BioVentures II-QP, L.P. MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG MPM Asset Management Investors 2001 LLC MPM BioVentures Strategic Fund, L.P. Ansbert Gadicke Luke Evnin |
(b) | Address of Principal Business Office or, if none, Residence |
c/o MPM Capital L.P. The John Hancock Tower 200 Clarendon Street, 54th Floor Boston, MA 02116 |
(c) | Citizenship |
All entities were organized in Delaware, except MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG which was organized in Germany. The individuals are United States citizens. |
(d) | Title of Class of Securities |
Common Stock |
(e) | CUSIP Number |
00826A 1G 9 |
Item 3. | If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable |
Page 9 of 13
MPM BioVentures II, LP |
109,213 | |||
MPM BioVentures II-QP, L.P. |
989,697 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
348,491 | |||
MPM Asset Management Investors 2001 LLC |
20,548 | |||
MPM BioVentures Strategic Fund, L.P. |
132,520 | |||
Ansbert Gadicke |
1,600,469 | * | ||
Luke Evnin |
1,600,469 | * | ||
Percent of Class: | ||||
MPM BioVentures II, LP |
0.76 | % | ||
MPM BioVentures II-QP, L.P. |
6.92 | % | ||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
2.43 | % | ||
MPM Asset Management Investors 2001 LLC |
0.14 | % | ||
MPM BioVentures Strategic Fund, L.P. |
0.93 | % | ||
Ansbert Gadicke |
11.18 | % | ||
Luke Evnin |
11.18 | % | ||
(b) Number of shares as to which the person has: | ||||
(i) Sole power to vote or to direct the vote | ||||
MPM BioVentures II, LP |
109,213 | |||
MPM BioVentures II-QP, L.P. |
989,697 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
348,491 | |||
MPM Asset Management Investors 2001 LLC |
20,548 | |||
MPM BioVentures Strategic Fund, L.P. |
132,520 | |||
Ansbert Gadicke |
0 | |||
Luke Evnin |
0 | |||
(ii) Shared power to vote or to direct the vote | ||||
MPM BioVentures II, LP |
0 | |||
MPM BioVentures II-QP, L.P. |
0 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2001 LLC |
0 | |||
MPM BioVentures Strategic Fund L.P. |
0 | |||
Ansbert Gadicke |
1,600,469 | * | ||
Luke Evnin |
1,600,469 | * |
Page 10 of 13
MPM BioVentures II, LP |
109,213 | |||
MPM BioVentures II-QP, L.P. |
989,697 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
348,491 | |||
MPM Asset Management Investors 2001 LLC |
20,548 | |||
MPM BioVentures Strategic Fund, L.P. |
132,520 | |||
Ansbert Gadicke |
0 | |||
Luke Evnin |
0 |
MPM BioVentures II, LP |
0 | |||
MPM BioVentures II-QP, L.P. |
0 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2001 LLC |
0 | |||
MPM BioVentures Strategic Fund, L.P. |
0 | |||
Ansbert Gadicke |
1,600,469 | * | ||
Luke Evnin |
1,600,469 | * |
* | The shares are held as follows: 989,697 by MPM BioVentures II-QP, L.P. (BV II QP), 109,213 by MPM BioVentures II, L.P. (BV II), 20,548 by MPM Asset Management Investors 2001 LLC (AM 2001), 348,491 by MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG (BV KG) and 132,520 by MPM BioVentures Strategic Fund, L.P. (MPM SF). BV II, BV II QP, BV KG and AM 2001 are under common control. MPM Asset Management II, L.P. (AM II GP) and MPM Asset Management II LLC (AM II LLC) are the direct and indirect general partners of BV II QP, BV II and BV KG. MPM BioVentures III GP, L.P. (BV III GP) and MPM BioVentures III LLC (BV III LLC) are the direct and indirect general partners of MPM SF. The Reporting Person is a member of AM II LP, AM II LLC, AM 2001, BV III GP and BV III LLC. |
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. |
Page 11 of 13
MPM BIOVENTURES II, L.P. | MPM BIOVENTURES II-QP, L.P. | |||||||||
By:
|
MPM Asset Management II, L.P., | By: | MPM Asset Management II, L.P., | |||||||
its General Partner | its General Partner | |||||||||
By:
|
MPM Asset Management II LLC, its General Partner |
By: | MPM Asset Management II LLC, its General Partner |
|||||||
By:
|
/s/ Luke Evnin | By: | /s/ Luke Evnin | |||||||
Name: Luke B. Evnin | Name: Luke B. Evnin | |||||||||
Title: Manager | Title: Manager | |||||||||
MPM BIOVENTURES GMBH & CO. PARALLEL-BETEILIGUNGS KG | MPM ASSET MANAGEMENT INVESTORS 2001 LLC | |||||||||
By: | /s/ Luke Evnin | |||||||||
By:
|
MPM Asset Management II LP, in its capacity as the Special Limited Partner | Name: Luke B. Evnin Title: Manager |
||||||||
By:
|
MPM Asset Management II LLC, its General Partner | |||||||||
By:
|
/s/ Luke Evnin | |||||||||
Name: Luke B. Evnin | ||||||||||
Title: Manager | ||||||||||
MPM BIOVENTURES STRATEGIC FUND, L.P. | MPM BIOVENTURES III GP, L.P. | |||||||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III LLC, | |||||||
its General Partner | its General Partner | |||||||||
By:
|
MPM BioVentures III LLC, | By: | /s/ Luke Evnin | |||||||
its General Partner | Name: Luke Evnin | |||||||||
Title: Series A Member | ||||||||||
By:
|
/s/ Luke Evnin | |||||||||
Name: Luke B. Evnin | ||||||||||
Title: Series A Member | ||||||||||
MPM BIOVENTURES III LLC | ||||||||||
By:
|
/s/ Luke Evnin | |||||||||
Name: Luke Evnin | ||||||||||
Title: Series A Member | ||||||||||
By:
|
/s/ Ansbert Gadicke | By: | /s/ Luke Evnin | |||||||
Name: Ansbert Gadicke | Name: Luke B. Evnin |
Page 12 of 13
MPM BIOVENTURES II, L.P. | MPM BIOVENTURES II-QP, L.P. | |||||||||
By:
|
MPM Asset Management II, L.P., | By: | MPM Asset Management II, L.P., | |||||||
its General Partner | its General Partner | |||||||||
By:
|
MPM Asset Management II LLC, its General Partner |
By: | MPM Asset Management II LLC, its General Partner |
|||||||
By:
|
/s/ Luke Evnin | By: | /s/ Luke Evnin | |||||||
Name: Luke B. Evnin | Name: Luke B. Evnin | |||||||||
Title: Manager | Title: Manager | |||||||||
MPM BIOVENTURES GMBH & CO. PARALLEL-BETEILIGUNGS KG | MPM ASSET MANAGEMENT INVESTORS 2001 LLC | |||||||||
By: | /s/ Luke Evnin | |||||||||
By:
|
MPM Asset Management II LP, in its capacity as the Special Limited Partner | Name: Luke B. Evnin Title: Manager |
||||||||
By:
|
MPM Asset Management II LLC, its General Partner | |||||||||
By:
|
/s/ Luke Evnin | |||||||||
Name: Luke B. Evnin | ||||||||||
Title: Manager | ||||||||||
MPM BIOVENTURES STRATEGIC FUND, L.P. | MPM BIOVENTURES III GP, L.P. | |||||||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III LLC, | |||||||
its General Partner | its General Partner | |||||||||
By:
|
MPM BioVentures III LLC, | By: | /s/ Luke Evnin | |||||||
its General Partner | Name: Luke Evnin | |||||||||
Title: Series A Member | ||||||||||
By:
|
/s/ Luke Evnin | |||||||||
Name: Luke B. Evnin | ||||||||||
Title: Series A Member | ||||||||||
MPM BIOVENTURES III LLC | ||||||||||
By:
|
/s/ Luke Evnin | |||||||||
Name: Luke Evnin | ||||||||||
Title: Series A Member | ||||||||||
By:
|
/s/ Ansbert Gadicke | By: | /s/ Luke Evnin | |||||||
Name: Ansbert Gadicke | Name: Luke B. Evnin |
Page 13 of 13